Your browser doesn't support javascript.
loading
Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovation.
Årdal, Christine; Baraldi, Enrico; Busse, Reinhard; Castro, Rosa; Ciabuschi, Francesco; Cisneros, José Miguel; Gyssens, Inge C; Harbarth, Stephan; Kostyanev, Tomislav; Lacotte, Yohann; Magrini, Nicola; McDonnell, Anthony; Monnier, Annelie A; Moon, Suerie; Mossialos, Elias; Peñalva, Germán; Ploy, Marie-Cécile; Radulovic, Momir; Ruiz, Adrián Alonso; Røttingen, John-Arne; Sharland, Michael; Tacconelli, Evelina; Theuretzbacher, Ursula; Vogler, Sabine; Sönksen, Ute Wolff; Åkerfeldt, Kerstin; Cars, Otto; O'Neill, Jim.
Affiliation
  • Årdal C; Antimicrobial Resistance Centre, Norwegian Institute of Public Health, Oslo 0213, Norway. Electronic address: chaa@fhi.no.
  • Baraldi E; Department of Engineering Sciences, Industrial Engineering and Management, Uppsala University, Uppsala, Sweden.
  • Busse R; Department of Health Care Management, Berlin University of Technology, Berlin, Germany.
  • Castro R; European Public Health Alliance, Brussels, Belgium.
  • Ciabuschi F; Department of Business Studies, Uppsala University, Uppsala, Sweden.
  • Cisneros JM; Department of Infectious Diseases, University Hospital Virgen del Rocio, IBiS, CIBERINFEC, Seville, Spain.
  • Gyssens IC; Department of Internal Medicine, Radboudumc Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, Netherlands.
  • Harbarth S; Hôpitaux Universitaires de Genève, Geneva, Switzerland.
  • Kostyanev T; Laboratoire National de Santé, Dudelange, Luxembourg.
  • Lacotte Y; University of Limoges, INSERM, CHU Limoges, RESINFIT, Limoges, France.
  • Magrini N; AIFA-Italian Medicines Agency, Rome, Italy.
  • McDonnell A; Center for Global Development, London, UK.
  • Monnier AA; Department of Medical Microbiology, Radboudumc Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, Netherlands.
  • Moon S; Graduate Institute of International and Development Studies, Geneva, Switzerland.
  • Mossialos E; London School of Economics and Political Science, London, UK.
  • Peñalva G; Institute of Biomedicine of Seville (IBiS), University of Seville/CSIC/University Hospital Virgen del Rocio, Seville, Spain.
  • Ploy MC; University of Limoges, INSERM, CHU Limoges, RESINFIT, Limoges, France.
  • Radulovic M; Agency for Medicinal Products and Medical Devices of the Republic of Slovenia, Ljubljana, Slovenia.
  • Ruiz AA; Graduate Institute of International and Development Studies, Geneva, Switzerland.
  • Røttingen JA; Norwegian Ministry of Foreign Affairs, Oslo, Norway.
  • Sharland M; Centre for Neonatal and Paediatric Infection, St George's University of London, London, UK.
  • Tacconelli E; University of Verona, Verona, Italy.
  • Theuretzbacher U; Center for Anti-Infective Agents, Vienna, Austria.
  • Vogler S; Austrian National Public Health Institute, Vienna, Austria; Department of Health Care Management, Berlin University of Technology, Berlin, Germany.
  • Sönksen UW; Statens Serum Institut, Copenhagen, Denmark.
  • Åkerfeldt K; ReAct Europe, Uppsala University, Uppsala, Sweden.
  • Cars O; ReAct Europe, Uppsala University, Uppsala, Sweden.
  • O'Neill J; The Review on Antimicrobial Resistance, London, UK.
Lancet ; 403(10422): e2-e4, 2024 Jan 13.
Article in En | MEDLINE | ID: mdl-36774936
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Bacterial Agents / Motivation Limits: Humans Language: En Journal: Lancet Year: 2024 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Bacterial Agents / Motivation Limits: Humans Language: En Journal: Lancet Year: 2024 Document type: Article